BOYU HU
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology HOUSTON, TX NPI 1033478144
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX Regeneron Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$46,641.61
- Category: General Payments
- Program years: PY2018–2024
- Record count: 51
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $17,766.96 across 25 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $14,517.50 | 7 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,160.00 | 1 |
| Compensation for serving as faculty or as a speaker for a medical education program | $453.74 | 2 |
| Food and Beverage | $318.79 | 9 |
| Travel and Lodging | $316.93 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $7,544.80 | 4 |
| PFIZER INC. | $2,160.00 | 1 |
| Kite Pharma, Inc. | $2,080.00 | 1 |
| Genentech USA, Inc. | $1,765.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $1,432.50 | 1 |
| ADC Therapeutics America, Inc. | $1,200.00 | 1 |
| Acerta Pharma LLC | $614.58 | 5 |
| ABBVIE INC. | $558.92 | 3 |
| TAIHO ONCOLOGY, INC. | $276.49 | 4 |
| ARGENX US, INC. | $58.60 | 1 |
| BeiGene USA, Inc. | $53.72 | 2 |
| Lilly USA, LLC | $22.35 | 1 |
By program year
Records — PY2024 (25)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.